| Authors: |
Ferrero S; Department of Medicine III, University Hospital Großhadern/LMU, München, Germany.; Division of Hematology, Department of Molecular Biotechnologies and Health Sciences, University of Torino, Torino, Italy., Pastore A; Department of Medicine III, University Hospital Großhadern/LMU, München, Germany., Scholz CW; Department of Oncology and Hematology, Vivantes Klinikum, Berlin, Germany., Forstpointner R; Department of Medicine III, University Hospital Großhadern/LMU, München, Germany., Pezzutto A; Charité University Medicine, Department of Hematology and Oncology, Berlin, Germany., Bergmann L; Medical Clinic II, University Hospital, Frankfurt, Germany., Trümper L; Department of Hematology and Oncology, Georg-August Universiität, Göttingen, Germany., Finke J; Hematology/Oncology, University Medical Center, Freiburg, Germany., Keller U; III Medical Department, Technische Universität München, Munich, Germany., Ghione P; Division of Hematology, Department of Molecular Biotechnologies and Health Sciences, University of Torino, Torino, Italy., Passera R; Biostatistician, Division of Nuclear Medicine, Città della Salute e della Scienza, University of Torino, Torino, Italy., Hiddemann W; Department of Medicine III, University Hospital Großhadern/LMU, München, Germany., Weigert O; Department of Medicine III, University Hospital Großhadern/LMU, München, Germany., Unterhalt M; Department of Medicine III, University Hospital Großhadern/LMU, München, Germany., Dreyling M; Department of Medicine III, University Hospital Großhadern/LMU, München, Germany. |
